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Abstract: Venous blood sampling (phlebotomy) is the most 
common invasive procedure performed in patient care. 
Guidelines on the correct practice of phlebotomy are avail-
able, including the H3-A6 guideline issued by the Clini-
cal Laboratory Standards Institute (CLSI). As the quality 
of practices and procedures related to venous blood sam-
ple collection in European countries was unknown, the 
European Federation of Clinical Chemistry and Labora-
tory Medicine (EFLM) Working Group for the Preanalytical 
Phase conducted an observational study in 12 European 
countries. The study demonstrated that the level of com-
pliance of phlebotomy procedures with the CLSI H3-A6 
guideline was unacceptably low, and that patient identi-
fication and tube labelling are amongst the most critical 
steps in need of immediate attention and improvement. 
The process of patient identification and tube labelling is 
an essential safety barrier to prevent patient identity mix-
up. Therefore, the EFLM Working Group aims to encourage 
and support worldwide harmonisation of patient identi-
fication and tube labelling procedures in order to reduce 
the risk of preanalytical errors and improve patient safety. 
With this Position paper we wish to raise awareness and 
provide recommendations for proper patient and sample 
identification procedures.
Keywords: harmonisation; patient identification; patient 
safety; phlebotomy; preanalytical phase; tube labelling.
Background and aims
Venous blood sampling (also known as “phlebotomy”) 
is the most common invasive procedure carried out in 
healthcare. It involves several distinct processes, all of 
which are vulnerable to errors [1, 2] potentially putting 
the patient safety at risk. Guidelines on the correct prac-
tice of phlebotomy are available, including the H3-A6 
guideline issued by the Clinical Laboratory Standards 
Institute (CLSI) in 2007 [3], recommendations issued by 
national societies [4, 5], or the guidelines on drawing 
blood  published by the World Health Organisation (WHO) 
in 2010 [6].
As the quality of practices and procedures related 
to blood sample collection in European countries was 
unknown, the European Federation of Clinical Chemistry 
and Laboratory Medicine Working Group for the Preana-
lytical Phase (EFLM WG-PRE) conducted an observa-
tional study in 12 European countries [7]. The aims of this 
study were to: 1) assess the level of compliance of phle-
botomy procedures with the CLSI H3-A6 guideline; and 
2) identify the most critical steps for immediate atten-
tion and improvement in EFLM member societies by 
creating a risk occurrence chart based on the observed 
error frequency and severity scoring. The study found 
that the overall level of compliance of phlebotomy pro-
cedure with the CLSI H3-A6 guideline was unacceptably 
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low and that tube labelling and patient identification 
were the most critical steps during phlebotomy. The tube 
labelling process and patient identification are essential 
safety barriers to prevent patient identity mix-up. CLSI 
H3-A6 recommends that tube labelling is done after the 
blood sampling, in the presence of the patient [3]. In our 
survey, tube labelling was done after the blood sampling 
in only 53.4% of all phlebotomies observed (179/336), 
and even 29.6% of them were not done in the presence 
of the patient (53/179) [7]. Labelling blood tubes in the 
absence of the patient (regardless to whether it is done 
before or after the blood sampling) was assessed as pos-
sibly life threatening error.
According to CLSI H3-A6, patient identification is 
crucial and it is the responsibility of the phlebotomist to 
ensure that blood is drawn from the individual designated 
on the request form [3]. The frequency of patient identifi-
cation error was 16.1% in our study and these errors were 
more frequent in emergency and outpatient departments 
than in clinical wards [7]. Identification errors are not 
always easily identifiable in clinical practice [8]. Never-
theless, several authors reported identification errors 
with unacceptable frequency in everyday work [9–11]. 
In their recent survey performed in Croatia, Dukic and 
Simundic have found that in almost 27% of cases, capil-
lary blood gas samples were not labelled with the patient 
name [12]. Furthermore, identification errors were among 
the most frequent mistakes observed in a cross-sectional 
comparative study performed in three government hos-
pitals in South Ethiopia from February to September 
2012 [13]. Valenstein and colleagues categorised errors 
involving clinical laboratories from 120 institutions, 
and showed that up to 56% of identification errors were 
primary specimen label errors [14]. Although the preva-
lence of adverse events due to identification errors can 
be as high as 6%, more than 70% of them may result in 
significant patient inconvenience, with unknown change 
in treatment or outcome [14]. Therefore, the improvement 
of patient identification by decreasing the frequency of 
errors is a continuing challenge in all types of blood col-
lection procedures and a crucial topic in many healthcare 
disciplines [15].
The EFLM WG-PRE is committed to promote the 
importance of preanalytical quality improvement and 
therefore, wishes to raise awareness about the need for 
immediate improvement of patient identification and 
tube labelling processes and call for the harmonisation of 
these important activities in the preanalytical phase. More 
specifically, the aim of this document is to provide EFLM 
WG-PRE recommendations for best practice in patient and 
sample identification.
Existing guidelines and EFLM 
WG-PRE recommendations
Patient identification is a key point in patient laboratory 
processing [16, 17]. Proper patient identification relies 
on at least two independent identifiers [18, 19]. The CLSI 
H3-A6 guideline describes requirements for identifying 
1) a patient who is conscious, 2) a patient who is uncon-
scious, too young, cognitively impaired, or does not speak 
the language of the phlebotomist, 3) a patient who is semi-
conscious, comatose or sleeping, and 4) an unidentified 
emergency patient [3].
Whenever possible, patient identification (for a 
patient who is conscious) should be active and engage the 
patient by asking an open ended question (e.g. What is 
your name?, What is your date of birth?). EFLM WG-PRE 
recommends that the person who verifies the identity of 
the patient (‘verifier’) should use at least two and prefer-
ably three independent identifiers to identify a patient, 
one of which is the full name. The other identifiers may be 
date of birth, address, health insurance number, etc. The 
name of the person who has verified the identity of the 
patient should also be documented.
The CLSI H3-A6 guideline [3] also states that patient 
and patient’s blood specimen must be positively iden-
tified at the time of collection. According to CLSI H3-A6 
guideline, tubes should be positively identified after 
filling, not before, with a firmly attached label bearing at 
least the following:
 – patient’s first and last names;
 – identification number;
 – date;
 – time (as required, e.g. therapeutic drug monitoring); 
and
 – identification of the person collecting the specimen.
Moreover, the tube should be labelled with the above 
information before leaving the side of the patient. This 
may be accomplished by hand writing a label, computer-
generated labels or a barcode label. Where possible, the 
labelled tube should be compared with patient’s identi-
fication bracelet or have the patient verify that the infor-
mation on the labelled tube is correct. In addition, there 
should be a mechanism to identify the person drawing the 
blood.
There has been a lot of debate about whether the 
tubes should be labelled before or after blood collection 
and some authors have argued that an undisputable evi-
dence to support that recommendation does not exist 
[20]. Standard operating procedures for phlebotomy may 
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differ with local preferences and available technological 
resources in an institution [21]. EFLM WG-PRE recom-
mends eliminating the requirement for tube labelling after 
collection. In our opinion, labelling before or after blood 
collection should be based on a prospective risk analysis 
of the phlebotomy process in each institution. Although 
some may argue that this could be too demanding, we still 
believe that risk based approach is the best way to estab-
lish a safe labelling policy and minimise risk of patient 
harm. Each institution should have a procedure to which 
all personnel should adhere. Tube labelling may also 
be performed prior to venepuncture, immediately after 
patient has been properly identified.
Regardless of the time when the blood tube is going to 
be labelled (before or after venepuncture), EFLM WG-PRE 
strongly recommends that tube labelling is done in pres-
ence of the patient. Otherwise, there is a risk that the tube 
will be left unlabelled and possibly mislabelled [4]. Actu-
ally, pre-labelling the tubes may even be more conveni-
ent since it allows that patient and sample identity are 
checked by comparing the information from the label with 
the patient identity, in the presence of the patient.
According to CLSI H3-A6 guideline, comprehensive 
information should be generated on the tube label for 
each venipuncture: 1) patient’s full name, 2) patient’s 
date of birth, 3) identification number, 4) time and date 
of sampling, and 5) identification of phlebotomist. EFLM 
WG-PRE recommends that the above mentioned essential 
information shall be registered within the laboratory in 
such a manner that the tube is traceable and unambigu-
ously linked to patient, collected sample, phlebotomist 
and a verifier (if different from a phlebotomist). However, 
we believe it is not essential all these data be recorded on 
the tube. We are in favour of labelling the blood tube with 
a barcode, as barcodes can hold all the aforementioned 
information. If not on the tube, this information should 
be documented in paper records or laboratory information 
management system. We also recommend that a minimum 
of two independent identifiers should be used to identify 
the tube. Understandably, the more data used to identify 
the blood tube, the smaller is the chance of patient iden-
tification errors.
Ideally, the use of automated systems (e.g. electronic 
order entry, barcoding, radiofrequency identification and 
biometrics) is advisable to minimise patient identification 
errors. However, it should be stressed that these systems 
may eliminate many transcription and identification 
errors, but do not per se guarantee that the identity on 
the label correctly identifies the identity of the individual 
from whom the blood specimen was obtained. Positive 
patient identification (PPID) refers to the correct initial 
identification of a patient and the absolute connection of 
all samples to that patient throughout the total examina-
tion process, including collection, analysis, and reporting 
[8]. The barcoded wristbands are increasingly worldwide 
used as a method for patient identification [21]. Both bar-
coding and radiofrequency identification could be used 
for electronic PPID. A barcode-based electronic PPID 
system includes barcoded patient wristbands, handheld 
computers onto which orders are downloaded, barcode 
scanners for confirming patient identity before blood 
sample collection, and portable printers to produce labels 
in the presence of the patient [22].
In addition, continuous education of the staff for 
venous blood sampling is highly advisable, since appro-
priate education of the personnel generates a better 
adherence to guideline recommendations for patient iden-
tification, tourniquet release, and test tube labelling [23, 
24]. Feedback, discussions and reflection amongst phle-
botomy personnel seem to be the best way to implement 
and sustain adherence to phlebotomy guideline practice 
and lead to long-term improvements in patient safety [25].
Finally, we recommend continuous monitoring of 
identification errors, preferably by repeated direct obser-
vations of phlebotomy practices and by using pre-analyt-
ical quality indicators [7, 26–28]. Ongoing monitoring is 
valuable, because it is strongly associated with a lower 
misidentification rate [14].
Final considerations and the way 
forward
EFLM aims to improve the level of harmonisation across 
the total examination process. The Federation, along 
with its WG-PRE, also wishes to take the lead in catalys-
ing various European and possibly global harmonisation 
projects in the preanalytical phase of laboratory testing. 
Particularly, for patient identification and tube labelling 
steps, EFLM WG-PRE recommends the following:
 – Healthcare institutions should have zero tolerance to 
patient identification errors;
 – A minimum two and preferably three unique patient 
identifiers (one of which is the full name of the 
patient) should be used for patient identification;
 – Patient and sample identity should always be checked 
in the presence of the patient;
 – The institution should have a policy and a written 
standard operating procedure defining the patient 
and sample identification, which is followed by all 
personnel;
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 – The institution should have a system in place to con-
tinuous monitor and hopefully reduce the frequency 
of the identification error rate;
 – A system should be in place for a continuous educa-
tion for all professions involved in phlebotomy;
 – EFLM member societies should adopt these recom-
mendations and encourage their implementation 
among healthcare institutions at their national level;
 – Standard writing bodies (CLSI, ISO) are encouraged to 
consider the present recommendations in the future 
revisions of their guidelines.
With this Position paper, the EFLM WG-PRE wishes to 
express continuing support to the worldwide harmonisa-
tion of phlebotomy practices. This document addresses 
two of the most critical steps in phlebotomy that need 
immediate attention: tube labelling and patient identifi-
cation. We believe that harmonisation of these important 
steps could effectively decrease the potential risk of pre-
analytical errors and improve patient safety.
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